CLINICAL TRIALS PROFILE FOR ZTLIDO
✉ Email this page to a colleague
All Clinical Trials for Ztlido
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04149938 ↗ | Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2016-09-28 | The purpose of this study is to characterize the comparative single-dose pharmacokinetics (bioequivalence) of lidocaine patch 1.8% (investigational product) versus Lidoderm® (lidocaine patch 5%,reference product). |
NCT04150536 ↗ | Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2016-01-08 | The objectives of this study are to evaluate the pharmacokinetic and adhesion performance of ZTlido (lidocaine topical system) 1.8% during physical exercise, application of heat, and under normal conditions. |
NCT04312750 ↗ | Adhesion of Lidocaine Topical System 1.8% | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2015-12-01 | The objective of this study is to evaluate the adhesion performance of ZTlido (lidocaine topical system) 1.8% in normal, healthy volunteers. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ztlido
Condition Name
Clinical Trial Locations for Ztlido
Trials by Country
Clinical Trial Progress for Ztlido
Clinical Trial Phase
Clinical Trial Sponsors for Ztlido
Sponsor Name